Group 1 - The company plans to change its name to Jiangsu Soho High Hope Group Corporation and its stock abbreviation to Suhao Huihong, while the stock code 600981 will remain unchanged [2][4][30] - The board of directors approved the name change and related amendments to the articles of association with a unanimous vote of 6 in favor [2][30] - The name change aims to align with the development strategy of Jiangsu Soho Holding Group and enhance the company's brand recognition and competitiveness [4][30] Group 2 - The company announced an extension of the Shanghai Hanfa Venture Capital Center's fund duration by one year and the business registration period by five years, with no management fees during the extension [7][9][33] - The Hanfa Fund has invested in three projects, with a total investment of 241.53 million yuan, and has achieved partial exits from two projects [8][9] - The fund's extension is intended to maximize investment returns and ensure the quality of project exits, aligning with the interests of all partners [10][33] Group 3 - A second extraordinary general meeting of shareholders is scheduled for September 2, 2025, to discuss the proposed name change and other matters [12][13][35] - The meeting will utilize both on-site and online voting methods, with specific timeframes for participation [14][16] - The board of directors will present several resolutions for approval, including the name change and fund extension [15][30][35]

Group 1 - The board of directors of Luoxin Pharmaceutical Group Co., Ltd. held its 27th meeting, which was legally convened and attended by all five directors [1] - The board approved a proposal to provide a guarantee of RMB 20 million for its subsidiary, Luoxin Anruowei Pharmaceutical (Chengdu) Co., Ltd., to support its operational and business expansion needs [1] - The guarantee will be valid for 12 months from the date of approval by the shareholders' meeting [1] Group 2 - The board proposed to convene the fourth extraordinary general meeting of shareholders in 2025 on August 18, 2025, which also received unanimous approval [2] - The proposal for the guarantee and the extraordinary general meeting will require approval from at least two-thirds of the voting rights at the shareholders' meeting [2]

Group 1 - The company held its eighth board meeting of 2025 on June 5, 2025, with all nine directors participating, complying with relevant laws and regulations [1][2] - The board approved a proposal to provide financing guarantees for seven wholly-owned subsidiaries, with a total guarantee amount not exceeding USD 1 billion from July 1, 2025, to June 30, 2026 [1][2] - The board also approved a proposal to apply for the registration and issuance of medium-term notes with a total scale not exceeding RMB 5 billion, pending shareholder approval [2] - The company plans to hold its 2024 annual general meeting on June 30, 2025, with the board secretary authorized to prepare specific details [2][3]

Group 1 - The company plans to issue new shares on the Shanghai Stock Exchange, with the resolution valid from the approval date of the 2024 annual general meeting until the 2025 annual general meeting [2] - The board of directors is authorized to handle all matters related to the issuance of shares, including the preparation and submission of relevant documents, determining the issuance plan, and managing the use of raised funds [2][3] - The issuance plan is subject to approval by the 2024 annual general meeting and must comply with relevant laws and regulations [3] Group 2 - The company has proposed an adjustment to the independent directors' remuneration, increasing it from RMB 52,000 to RMB 65,000 per year, pending approval at the 2024 annual general meeting [5][6] - This adjustment aims to enhance the motivation of independent directors and align their compensation with their responsibilities and the company's operational status [6] Group 3 - The company intends to use idle self-owned funds for cash management, with a maximum investment amount of RMB 400 million in short-term, low-risk financial products [10][11] - The investment aims to improve the efficiency of the company's idle funds while ensuring daily operational needs and fund safety [11][17] - The board has authorized the chairman to make investment decisions within the specified limits [14] Group 4 - The company has decided to abolish the supervisory board, transferring its powers to the audit committee of the board, and will revise the articles of association accordingly [19][20] - This change is in compliance with the revised Company Law and aims to streamline governance [19] Group 5 - The 2024 annual general meeting is scheduled for May 8, 2025, with both on-site and online voting options available for shareholders [22][23] - The meeting will address various proposals that have been approved by the board, including those requiring special resolutions and those involving related party transactions [25]